Literature DB >> 23871117

A novel rating scale for the measurement of apathy in institutionalized persons with dementia: the APADEM-NH.

Luis Agüera-Ortiz1, Nuria Gil-Ruiz2, Isabel Cruz-Orduña2, Isabel Ramos-García2, Ricardo S Osorio3, Meritxell Valentí-Soler2, Javier Olazarán-Rodriguez2, José L Dobato-Ayuso2, Krista Lanctôt4, Pablo Martínez-Martín5.   

Abstract

OBJECTIVE: Apathy is one of the most frequent symptoms of dementia, still needing better measurement methods. The objective of this study was to validate a new scale for apathy in institutionalized persons with dementia (APADEM-NH).
METHODS: The scale includes 26 items distributed in three dimensions: Deficit of Thinking and Self-Generated behaviors (DT): 13 items, Emotional Blunting (EB): 7 items, and Cognitive Inertia (CI): 6 items. The sample included 100 institutionalized patients (90% female) with probable Alzheimer disease (AD) (57%), possible AD (13%), AD + cerebral vascular disease (17%), Lewy body dementia (11%), and Parkinson associated to dementia (2%), covering all stages of dementia severity according to the Global Deterioration Scale and Clinical Dementia Rating. Additional assessments were the Apathy Inventory, Neuropsychiatric Inventory, Cornell Scale for Depression, and the tested scale. Re-test and inter-rater reliability were carried out in 50 patients.
RESULTS: All subscales lacked relevant floor and ceiling effects (<15%). Internal consistency for each dimension was (Cronbach's α): DT = 0.88, EB = 0.83, CI = 0.88; item-total correlations were >0.40; and item homogeneity 0.36-0.51. Test-retest reliability for the items was kW = 0.48-0.92; for the subscales, intraclass correlation coefficient (ICC) = 0.80-0.88; and for the total score, ICC = 0.90. Inter-rater reliability reached kW values of 0.84-1.00; subscales ICC, 0.97-0.99, and total score ICC, 0.99. Standard error of measurement for total score was 6.41 and internal validity ranged from rS = 0.69-0.80.
CONCLUSIONS: APADEM-NH proved to be feasible, reliable, and valid for apathy assessment in institutionalized patients suffering mild to severe dementia, discerning well between apathy and depression.
Copyright © 2015 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apathy; dementia; institutionalized persons; psychometrics; rating scale; validation study

Mesh:

Year:  2013        PMID: 23871117     DOI: 10.1016/j.jagp.2013.01.079

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  5 in total

1.  Beyond memory: a focus on the other neuropsychiatric symptoms of dementia.

Authors:  Matthew E Peters; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2015-02       Impact factor: 4.105

2.  Are there distinct dimensions of apathy? The argument for reappraisal.

Authors:  Shannon S Dickson; Masud Husain
Journal:  Cortex       Date:  2022-01-25       Impact factor: 4.644

3.  Person-centered assessment of apathy and resistance to care in people living with dementia: Review of existing measures.

Authors:  Benjamin T Mast; Emilee M Ertle; Ann Kolanowski; Gail Mountain; Esme Moniz-Cook; Margareta Halek
Journal:  Alzheimers Dement (N Y)       Date:  2022-07-26

Review 4.  Methodologies Used to Study the Feasibility, Usability, Efficacy, and Effectiveness of Social Robots For Elderly Adults: Scoping Review.

Authors:  Aysan Mahmoudi Asl; Mauricio Molinari Ulate; Manuel Franco Martin; Henriëtte van der Roest
Journal:  J Med Internet Res       Date:  2022-08-01       Impact factor: 7.076

5.  Social robots in advanced dementia.

Authors:  Meritxell Valentí Soler; Luis Agüera-Ortiz; Javier Olazarán Rodríguez; Carolina Mendoza Rebolledo; Almudena Pérez Muñoz; Irene Rodríguez Pérez; Emma Osa Ruiz; Ana Barrios Sánchez; Vanesa Herrero Cano; Laura Carrasco Chillón; Silvia Felipe Ruiz; Jorge López Alvarez; Beatriz León Salas; José M Cañas Plaza; Francisco Martín Rico; Gonzalo Abella Dago; Pablo Martínez Martín
Journal:  Front Aging Neurosci       Date:  2015-09-03       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.